United States v. Kroll

73 M.J. 581, 2014 WL 545937, 2014 CCA LEXIS 75
U S Coast Guard Court of Criminal Appeals·Decided February 12, 2014·No. CGCMG 0290; Docket No. 1372·Published

Opinion

McClelland, Chief Judge:

Appellant was tried by general court-martial, military judge alone. Pursuant to her pleas of guilty, entered in accordance with a pretrial agreement, Appellant was convicted of four specifications of wrongfully using drugs (marijuana, oxymorphone (“Opana”), cocaine, and heroin), two specifications of wrongfully distributing drugs (hydrocodone combination product (“Vieodin”) and methamphetamine), one specification of wrongfully using methamphetamine while on duty, and one specification of wrongfully introducing methamphetamine onto a military installation, all in violation of Article 112a, Uniform Code of Military Justice (UCMJ). The military judge sentenced Appellant to confinement for two years, reduction to E-l, forfeiture of all pay and allowances, and a bad-conduct discharge. The Convening Authority approved the sentence, but suspended confinement in excess of 12 months, in accordance with the pretrial agreement.

Before this court, Appellant has assigned the following errors:

I. Appellant was prejudiced by the failure of the Convening Authority to consider substantial clemency matters brought to the Convening Authority’s attention prior to action being taken.
II. The facts elicited during the providence inquiry into Specifications 5 and 9 provided an insufficient basis for the military judge to accept Appellant’s guilty pleas.

We specified this issue: Whether Appellant’s pleas of guilty to Specifications 2 and 5 were provident, when the military judge informed her, in connection with those specifications, that a controlled substance is one that is illegal to possess, even though the two substances alleged in the specifications apparently have currently accepted medical uses in treatment in the United States.

We find Appellant’s pleas provident, with a sufficient factual basis, including her pleas to Specifications 5 and 9 alleging distribution. We discuss the specified issue and the first issue, and affirm.

“A controlled substance is one that is illegal to possess”

Specification 2 alleges wrongful use of “ox-ymorphone (‘Opana’), a Schedule II controlled substance.” Specification 5 alleges wrongful distribution of “hyrdoeodone1 combination product (Wieodin’), a Schedule III controlled substance.”

During the providence inquiry, in the course of discussing the first specification, which alleged use of marijuana, the military judge explained as follows:

To be punishable under Article 112a2, use of a controlled substance must be wrongful, that is without legal justification or authorization. Use of a controlled substance is not wrongful if such act or acts are (a) done pursuant to legitimate law enforcement activities, for example, an informant who is forced to use drugs as part of an undercover operation to keep from being discovered is not guilty of wrongful use or (b) done by authorized personnel in the performance of medical duties or experiments. A controlled substance is one that is illegal to possess. Marijuana is a controlled substance under the laws of the United States.

(R. at 32-33.)

When it came to the second specification, alleging use of Opana, after reciting the elements, the military judge said, “The same definitions that I stated above earlier apply here.” (R. at 36.) He went on, “A controlled substance is one that is illegal to possess. Opana is a controlled substance under the laws of the United States.” (Id.) When asking Appellant about the facts, he elicited that she obtained the Opana from a civilian friend, that she had no authority to use it, [583]*583and that her use of it was wrongful. (R. at 37-38.)

After two more specifications alleging use of illegal drugs, the military judge began discussing the fifth specification, alleging distribution of Vieodin. After reciting the elements and defining distribution, he explained:

To be punishable under Article 112a3, distribution of a controlled substance must be wrongful. Distribution of a controlled substance is wrongful if it is without legal justification or authorization. Distribution of a controlled substance is not wrongful if such acts or act are: (a) done pursuant to legitimate law enforcement activities, for example, if an informant who delivers drags is part of an undercover operation is not guilty of wrongful distribution or (b) done by authorized personnel in the performance of medical duties. A controlled substance is one that it is illegal to possess. Vieodin is a controlled substance under the laws of the United States.

(R. at 46.) He elicited from Appellant that a civilian friend gave the Vieodin to her, that she had no authority to distribute it, and that she knew it was wrongful when she distributed it. (R. at 48.)

The Stipulation of Fact, Prosecution Exhibit 1, includes stipulations that Appellant knew Opana and Vieodin were controlled substances and that their use was wrongful when she used or distributed them; that she had no legal justification or authorization for using Opana and for distributing Vieodin; and that she traded the Vieodin pill for a cigarette.

The following provisions of the Controlled Substances Act are relevant to this ease:

21 U.S.C. § 812, establishing schedules of controlled substances, and particularly
21 U.S.C. § 812(b), establishing criteria for placing drags in the schedules;
21 U.S.C. § 811, authorizing regulations adding drugs and substances to the schedules of controlled substances;
21 C.F.R. § 1308.12, Schedule II of controlled substances; and
21 C.F.R. § 1308.13, Schedule III of controlled substances.

We take notice of the following:

That oxymorphone appears on Schedule II, at 21 C.F.R. § 1308.12(b)(l)(xiv).
That hydrocodone combination product is included on Schedule III, at 21 C.F.R. § 1308.13(e)(l)(iv).
That substances listed on Schedule II and Schedule III have currently accepted medical uses in treatment in the United States, according to 21 U.S.C. .§ 812(b)(2)(B) and 21 U.S.C. § 812(b)(3)(B) respectively, in contrast to substances listed on Schedule I, which have no currently accepted medical uses in treatment in the United States, according to 21 U.S.C. § 812(b)(1)(B).

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Kroll, 73 M.J. 581, 2014 WL 545937, 2014 CCA LEXIS 75 (uscgcoca 2014).

73 M.J. 581 (United States v. Kroll) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Hartman
69 M.J. 467 (Court of Appeals for the Armed Forces, 2011)
United States v. Inabinette
66 M.J. 320 (Court of Appeals for the Armed Forces, 2008)
United States v. Medina
66 M.J. 21 (Court of Appeals for the Armed Forces, 2008)
United States v. O'Connor
58 M.J. 450 (Court of Appeals for the Armed Forces, 2003)
United States v. Stephens
56 M.J. 391 (Court of Appeals for the Armed Forces, 2002)
United States v. Care
18 C.M.A. 535 (United States Court of Military Appeals, 1969)
United States v. Craig
28 M.J. 321 (United States Court of Military Appeals, 1989)